Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Radiation Oncology/Therapy: Page 34
Bruce Power sends first shipment of lutetium-177 to Munich
By
AuntMinnie.com staff writers
Canada's Bruce Power has produced its first shipment of the radioisotope lutetium-177 at its nuclear power reactor in Bruce County, Ontario.
June 20, 2022
NorthStar names Scholz as new president and COO
By
AuntMinnie.com staff writers
NorthStar Medical Radioisotopes has promoted Frank Scholz, PhD, to president and chief operating officer (COO).
June 20, 2022
B dot touts progress in proton therapy development
By
AuntMinnie.com staff writers
B dot Medical is highlighting a new milestone in the development of its ultracompact proton therapy system.
June 19, 2022
Blue Earth touts positive prostate cancer trial results
By
AuntMinnie.com staff writers
Blue Earth Therapeutics is highlighting clinical study results that suggest that its radiopharmaceutical labeled with lutetium-177 is effective for treating metastatic, castrate-resistant prostate cancer.
June 15, 2022
AI method reduces radiation exposure via virtual PET/CT images
By
AuntMinnie.com staff writers
An artificial intelligence (AI) method can generate virtual attenuation-corrected PET/CT images -- which cuts patients' radiation exposure, according to research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting.
June 14, 2022
Fusion and Niowave ink $5M collaboration
By
AuntMinnie.com staff writers
McMaster University spin-off company Fusion Pharmaceuticals and superconducting accelerator technology firm Niowave have inked a $5Â million supply agreement for the development, production, and supply of actinium-225.
June 13, 2022
Do nuclear medicine physicians need a new identity?
By
Will Morton
VANCOUVER, BC - It's time to embrace a new identity in nuclear medicine -- namely, that of the "nuclear oncologist," said Dr. Richard Wahl in the president's address June 12 at the Society of Nuclear Medicine and Molecular Imaging annual meeting.
June 12, 2022
VA Ann Arbor expands use of ViewRay radiation therapy
By
AuntMinnie.com staff writers
Radiation therapy developer ViewRay announced that the VA Ann Arbor Healthcare System (VAAAHS) is expanding to include advanced radiation therapy services through the MRIdian MRI-guided radiation system at the Lieutenant Colonel Charles S. Kettles VA Medical Center.
June 9, 2022
Imaging Endpoints, ImaginAb expand partnership
By
AuntMinnie.com staff writers
Contract research organization Imaging Endpoints and immuno-PET developer ImaginAb have inked a license agreement to supply clinical doses of ImaginAb's investigational zirconium-89 crefmirlimab berdoxam CD8 Immuno-PET agent to biopharma companies.
June 6, 2022
NorthStar inks supply deal with Curie Therapeutics
By
AuntMinnie.com staff writers
NorthStar Medical Radioisotopes has inked a long-term supply agreement with Curie Therapeutics for NorthStar's actinium-225 therapeutic radioisotope.
June 6, 2022
Older breast cancer patients may not need radiotherapy
By
AuntMinnie.com staff writers
Women over the age of 55 with early-stage breast cancer may not need radiotherapy after breast-conserving surgery, according to research presented June 7 at the American Society of Clinical Oncology's annual meeting in Chicago.
June 6, 2022
ViewRay MRI system used at Henry Ford Health
By
AuntMinnie.com staff writers
ViewRay said that Detroit-based Henry Ford Health recently became the first center with the company's MRIdian radiation therapy technology to complete a full patient treatment course using the MRIdian A3i system.
June 2, 2022
Previous Page
Page 34 of 468
Next Page
